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Background:  A few randomized trials have compared long-term survival following coronary artery bypass graft (CABG) surgery and stenting with 
bare-metal stents (BMS) with lengths of follow-up of 5 years. However, there is a lack of data on the long-term survival following CABG surgery and 
stenting with BMS in real-world practice. Our previous study found that CABG surgery was associated with lower risk of mortality in patients with 
multivessel disease during a follow-up of 3 years. In this study, we will test the hypothesis that CABG surgery is related to lower risk of long-term (8-
year) mortality for multivessel disease.
Methods:  The study population consists of 18,359 patients with multivessel disease who underwent CABG surgery and 13,377 patients who 
underwent stenting with BMS in 1999-2000 in New York. Baseline risk factors were obtained from the New York State’s Cardiac Surgery Reporting 
System and Percutaneous Coronary Intervention Reporting System. Vital status through the end of 2007 of these patients was ascertained using 
the National Death Index. CABG and stent patients were pair matched on the diseased vessels and the propensity of being treated by CABG surgery 
(instead of stenting). A pair-matched analysis was conducted to compare survival between the two procedures during a follow-up period of 8 years 
on average.
Results:  A total of 7,235 pairs of CABG and stent patients were matched. There were no significant differences in baseline risk factors between the 
two groups of matched patients. Overall, the Kaplan-Meier survival analysis showed that the 8-year survival rates were 78.0% for CABG surgery and 
71.2% for stenting (hazard ratio = 0.68, 95% confidence interval: 0.64 to 0.74, P<0.0001). The survival advantage for CABG surgery was consistently 
observed in the subgroups of patients classified by the diseased vessels. The hazard ratio for mortality ranged from 0.53 (P<0.001) for patients with 
3 diseased vessels with a diseased proximal left anterior descending (LAD) artery to 0.78 (P=0.046) for patients with 2 diseased vessels without a 
diseased LAD artery.
Conclusion: CABG surgery is associated with lower long-term mortality compared to stenting with BMS.
